Enhanced activity of CMP-NeuAc:Galβ1-4GlcNAc:α2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Cancer Letters

• Publication date

  1993-12-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0304-3835(93)90056-F
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of CMP-sialic acid transport in human liver and colorectal cancer cell lines by a sialic acid nucleoside conjugate (KI-8110).

  1993cited by this paper
• Sialyltransferase: a novel acute-phase reactant.

  1993cited by this paper
• Human liver and human placenta both contain CMP‐NeuAc:Galβ1→4GlcNAc‐R α2→3‐ as well as α2→6‐sialyltransferase activity

  1992cited by this paper
• Alterations in cell surface carbohydrate composition of a human colon carcinoma cell line affect adhesion to extracellular matrix components.

  1992cited by this paper
• Sialyltransferase activity and hepatic tumor growth in a nude mouse model of colorectal cancer metastases.

  1992cited by this paper
• Enhanced CMP‐NeuAc:Galβ1, 4GlcNAc‐R α2, 6 sialyltransferase activity of human colon cancer xenografts in athymic nude mice and of xenograft‐derived cell lines

  1992cited by this paper
• Comparison of sialyl- and α-1,3-galactosyltransferase activity in NIH3T3 cells transformed with ras oncogene: increased β-galactoside α-2,6-sialyltransferase

  1992cited by this paper
• Cloning and expression of the Gal beta 1, 3GalNAc alpha 2,3-sialyltransferase.

  1992cited by this paper
• Primary structure of Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase determined by mass spectrometry sequence analysis and molecular cloning. Evidence for a protein motif in the sialyltransferase gene family.

  1992cited by this paper
• Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials.

  1992cited by this paper
• Tumor cell adhesion to endothelial cells: endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor specific for colon carcinoma cells.

  1991cited by this paper
• α2, 6 sialylation of N‐acetyllactosaminic sequences in human colorectal cancer cell lines. Relationship with non‐adherent growth

  1991cited by this paper
• Sialic acid dependent cell adhesion to collagen IV correlates with in vivo tumorigenicity of the human colon carcinoma sublines HCT116, HCT116a and HCT116b.

  1990cited by this paper
• Cell surface sialoprotein alterations in metastatic murine colon cancer cell lines selected in an animal model for colon cancer metastasis.

  1990cited by this paper
• Evidence that β1‐6 branched Asn‐linked oligosaccharides on metastatic tumor cells facilitate invasion of basement membranes

  1989cited by this paper
• Mosaicism in the expression of tumor-associated carbohydrate antigens in human colonic and gastric cancers.

  1989cited by this paper
• Increased CMP‐NeuAc:Galβ1,4GlcNAc‐R α2,6 sialyltransferase activity in human colorectal cancer tissues

  1989cited by this paper
• Tumorigenic human squamous lung cancer cells have defined cell surface carbohydrates that are absent from nontumorigenic cells.

  1988cited by this paper
• Glycosylation-dependent collagen-binding activities of two membrane glycoproteins in MDAY-D2 tumor cells.

  1988cited by this paper
• Purification of alpha 2,6-sialyltransferase from rat liver by dye chromatography.

  1988cited by this paper
• Comparative Study of the Levels of Sialyltransferases Responsible for the Formation of Sugar Chains in Glycoproteins and Gangliosides in Rat Liver and Hepatomas

  1988cited by this paper
• Plasma sialyltransferase as a tumor marker.

  1988cited by this paper
• Activation and transfer of novel synthetic 9-substituted sialic acids.

  1987cited by this paper
• Primary structure of beta-galactoside alpha 2,6-sialyltransferase. Conversion of membrane-bound enzyme to soluble forms by cleavage of the NH2-terminal signal anchor.

  1987cited by this paper
• Effect of cancer-related and drug-induced alterations in surface carbohydrates on the invasive capacity of mouse and rat cells.

  1986cited by this paper
• Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins

  1986cited by this paper
• A high-pressure liquid chromatography method for the detection of O-β-d-galactosyl-(1→4)-2-acetamido-2-deoxy-d-glucose α-(2→3)- and α-(2→6)-sialyltransferases

  1983cited by this paper
• SECTION 3 – Glycosyltransferases in Cancer

  1982cited by this paper
• High-pressure liquid chromatography of sialic acid-containing oligosaccharides.

  1981cited by this paper
• Properties of a CMP-N-acetylneuraminic acid: glycoprotein sialyltransferase in human serum and erythrocyte membranes.

  1971cited by this paper

• Sialylation in the gut: From mucosal protection to disease pathogenesis.

  2024cites this paper
• Transcription of human β-galactoside α2,6-sialyltransferase (hST6Gal I) is downregulated by curcumin through AMPK signaling in human colon carcinoma HCT116 cells

  2023cites this paper
• Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer

  2022cites this paper
• Profound Diversity of the N-Glycome from Microdissected Regions of Colorectal Cancer, Stroma, and Normal Colon Mucosa

  2022cites this paper
• β-1,4-Galactosyltransferase-V colorectal cancer biomarker immunosensor with label-free electrochemical detection.

  2022cites this paper
• Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells

  2021cites this paper
• Regulation of human β-galactoside α2,6-sialyltransferase (hST6Gal I) gene expression during differentiation of human osteoblastic MG-63 cells

  2020cites this paper
• Electrochemical biosensing platform based on complex biantennary N-glycan for detecting enzymatic sialylation processes.

  2020cites this paper
• Mass spectrometry analysis reveals aberrant N-glycans in colorectal cancer tissues.

  2019cites this paper
• Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types.

  2019cites this paper
• B cells suppress medullary granulopoiesis by an extracellular glycosylation-dependent mechanism

  2019cites this paper
• A streamlined strategy for rapid and selective analysis of serum N-glycome.

  2019cites this paper
• Dual-type responsive electrochemical biosensor for the detection of α2,6-sialylated glycans based on AuNRs-SA coupled with c-SWCNHs/S-PtNC nanocomposites signal amplification.

  2019cites this paper
• The impact of ST 6 GalI in the progression of colorectal cancer

  2018cites this paper
• α2,6-linked sialic acid serves as a high-affinity receptor for cancer oncolytic virotherapy with Newcastle disease virus

  2017cites this paper
• The blood‐borne sialyltransferase ST6Gal‐1 is a negative systemic regulator of granulopoiesis

  2017cites this paper
• Monoclonal Antibodies Against Tumour-Associated Carbohydrate Antigens

  2017cites this paper
• Novel fusion proteins based on recombinant lectins for delivery of a cytotoxic peptide specifically to cancer cells

  2016cites this paper
• Glycosylation characteristics of colorectal cancer.

  2015cites this paper
• Ultrasensitive electrochemical biosensor based on reduced graphene oxide-tetraethylene pentamine-BMIMPF6 hybrids for the detection of α2,6-sialylated glycans in human serum.

  2015cites this paper
• Mass Spectrometry-Based N-Glycomics of Colorectal Cancer

  2015cites this paper
• Advances in glycoproteomics and glyco-biomarker discovery studies:: development and application of liquid chromatography and mass spectrometry platforms to cancer samples.

  2014cites this paper
• High-throughput determination of the site-specific N-sialoglycan occupancy rates by differential oxidation of glycoproteins followed with quantitative glycoproteomics analysis.

  2014cites this paper
• Altered Tumor-Cell Glycosylation Promotes Metastasis

  2014cites this paper
• Aiming at the sweet side of cancer: aberrant glycosylation as possible target for personalized-medicine.

  2014cites this paper
• Platelets Support Extracellular Sialylation by Supplying the Sugar Donor Substrate*♦

  2014cites this paper
• Salivary Glyco-sialylation changes monitors oral carcinogenesis

  2014cites this paper
• Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and α-2,3-linked sialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines.

  2014cites this paper
• Sialosignaling: sialyltransferases as engines of self-fueling loops in cancer progression.

  2014cites this paper
• Comparative Studies of the Proteome, Glycoproteome, and N-Glycome of Clear Cell Renal Cell Carcinoma Plasma before and after Curative Nephrectomy

  2014cites this paper
• Modification of Glycosylation Mediates the Invasive Properties of Murine Hepatocarcinoma Cell Lines to Lymph Nodes

  2013cites this paper
• Increasing the α 2, 6 Sialylation of Glycoproteins May Contribute to Metastatic Spread and Therapeutic Resistance in Colorectal Cancer

  2013cites this paper
• The role of ST6Gal-I sialylation in Fas (CD95) death receptor function and tumorigenesis

  2012cites this paper
• Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.

  2012cites this paper
• Altered Expression of Sialylated Glycoproteins in Breast Cancer Using Hydrazide Chemistry and Mass Spectrometry*

  2012cites this paper
• Regulation of the metastatic cell phenotype by sialylated glycans

  2012cites this paper
• Glycan profiling of endometrial cancers using lectin microarray

  2012cites this paper
• Cleavage of ST6Gal I by Radiation-Induced BACE1 Inhibits Golgi-Anchored ST6Gal I-Mediated Sialylation of Integrin β1 and Migration in Colon Cancer Cells

  2012cites this paper
• Loss of UDP‐N‐acetylglucosamine 2‐epimerase/N‐acetylmannosamine kinase (GNE) induces apoptotic processes in pancreatic carcinoma cells

  2012cites this paper
• Mechanisms of cancer-associated glycosylation changes.

  2012cites this paper
• Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma Cells*

  2011cites this paper
• Disease-Free Survival of Colorectal Cancer Patients in Relation to CDw75 Antigen Expression

  2011cites this paper
• Analysis of serum protein glycosylation with antibody-lectin microarray for high-throughput biomarker screening.

  2011cites this paper
• High‐throughput lectin magnetic bead array‐coupled tandem mass spectrometry for glycoprotein biomarker discovery

  2011cites this paper
• Emerging Role of α2,6-Sialic Acid as a Negative Regulator of Galectin Binding and Function*

  2010cites this paper
• Involvement of ST6Gal I in the biosynthesis of a unique human colon cancer biomarker candidate, alpha2,6-sialylated blood group type 2H (ST2H) antigen.

  2010cites this paper
• Involvement of ST 6 Gal I in the biosynthesis of a unique human colon cancer biomarker candidate , a 2 , 6-sialylated blood group type 2 H ( ST 2 H ) antigen

  2010cites this paper
• Chemical and Biological Characterization of Oleanane Triterpenoids from Soy

  2009cites this paper
• Carbohydrate Markers in Colon Carcinoma

  2009cites this paper
• Synthesis and expression of CDw75 antigen in human colorectal cancer

  2009cites this paper
• Enhanced sialyltransferases transcription in cervical intraepithelial neoplasia.

  2009cites this paper
• β1,3-Galactosyltransferases-4/5 Are Novel Tumor Markers for Gynecological Cancers

  2009cites this paper
• N-Acetylglucosamine 6-O-sulfotransferase-2 as a tumor marker for uterine cervical and corpus cancer

  2009cites this paper
• The Metastatic Stage-dependent Mucosal Expression of Sialic Acid is a Potential Marker for Targeting Colon Cancer with Cationic Polymers

  2008cites this paper
• alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo.

  2008cites this paper
• Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms.

  2008cites this paper
• Molekulargenetische Analyse der Splicingvarianten der ST6Gal-I in humanen kolorektalen Karzinomen und gesunder kolorektaler Mukosa

  2008cites this paper
• Tissue and serum α2-3- and α2-6-linkage specific sialylation changes in oral carcinogenesis

  2008cites this paper
• Protein Sialylation by Sialyltransferase Involves Radiation Resistance

  2008influential citation
• Aberrant expression of glycosylation in juvenile gastrointestinal stromal tumors

  2008cites this paper
• Alpha 2,6‐Sialyltransferase I Expression in the Placenta of Patients with Preeclampsia

  2007cites this paper
• Glycobiology Protocols

  2007cites this paper
• β-Galactoside α2,6-Sialyltransferase and the Sialyl α2,6-Galactosyl-Linkage in Tissues and Cell Lines

  2006cites this paper
• Phenotypic changes induced by expression of β-galactoside α2,6 sialyltransferase I in the human colon cancer cell line SW948

  2006cites this paper
• Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility.

  2005cites this paper
• Elevation of ST6Gal I Activity in Malignant and Transitional Tissue in Human Colorectal Cancer

  2005cites this paper
• Up-regulating Cell Motility Adenocarcinoma , May Contribute to Cancer Progression by Integrins , Observed in Colon 1 β Hypersialylation of Updated

  2005cites this paper
• Monitoring glycosylation pattern changes of glycoproteins using multi-lectin affinity chromatography.

  2005cites this paper
• Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids.

  2005cites this paper
• Correlation Analysis between Tumorous Associated Antigen Sialyl-Tn Expression and ST6GalNAc I Activity in Human Colon Adenocarcinoma

  2004cites this paper
• On the Role of Cell Surface Carbohydrates and their Binding Proteins (lectins) in Tumor Metastasis

  2004cites this paper
• Clinical usefulness of alterations in sialic acid, sialyl transferase and sialoproteins in breast cancer

  2004cites this paper
• Variant glycosylation: an underappreciated regulatory mechanism for beta1 integrins.

  2004cites this paper
• Ras oncogene induces β‐galactoside α2,6‐sialyltransferase (ST6Gal I) via a RalGEF‐mediated signal to its housekeeping promoter

  2004cites this paper
• Synthesis and evaluation of phosphoramidate amino acid-based inhibitors of sialyltransferases.

  2003cites this paper
• Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer.

  2003cites this paper
• Glycosyltransferase expression in human colonic tissue examined by oligonucleotide arrays.

  2003cites this paper
• Transcriptional regulation of human β-galactoside α2,6-sialyltransferase (hST6Gal I) gene in colon adenocarcinoma cell line

  2003cites this paper
• Clinical Relevance of Sialyltransferases ST6GAL-I and ST3GAL-III in Gastric Cancer

  2003cites this paper
• Cell surface α2,6-sialylation affects adhesion of breast carcinoma cells

  2002cites this paper
• Alterations of CMP-NeuAc:Asialofetuin Sialyltransferase Activities in Human Colorectal Adenocarcinoma

  2002cites this paper
• Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions.

  2002cites this paper
• Correlation between the sialylation of cell surface Thomsen-Friedenreich antigen and the metastatic potential of colon carcinoma cells in a mouse model

  2001cites this paper
• Soyasaponin I, a potent and specific sialyltransferase inhibitor.

  2001cites this paper
• Sialyltransferases in cancer

  2001cites this paper
• Application of a lectin from the mushroom Polysporus squamosus for the histochemical detection of the NeuAcα2,6Galβ1,4Glc/GlcNAc sequence of N-linked oligosaccharides: a comparison with the Sambucus nigra lectin

  2001cites this paper
• Biosynthesis of the cancer-related sialyl-α2,6-lactosaminyl epitope in colon cancer cell lines expressing β-galactoside α2,6-sialyltransferase under a constitutive promoter

  2001cites this paper
• Clinical Correlations of α2,6-Sialyltransferase Expression in Colorectal Cancer Patients

  2000cites this paper
• Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases

  2000cites this paper
• Immunohistochemical Analysis of Sialic Acid and Fucose Composition in Human Colorectal Adenocarcinoma

  2000cites this paper
• β‐galactoside α2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with sambucus nigra agglutinin

  2000cites this paper
• Overexpression of the α2,6 (N) sialyltransferase enzyme in human and rat neural cell lines is associated with increased expression of the polysialic acid epitope

  1999cites this paper
• Altered mRNA expression of glycosyltransferases in human gastric carcinomas.

  1999cites this paper
• Differential expression of the hepatic transcript of β‐galactoside α2,6‐sialyltransferase in human colon cancer cell lines

  1999cites this paper
• Preparation and characterization of differently aggregated colorectal carcinoma cell subpopulations from surgical specimens.

  1998cites this paper
• Cancer-Associated Glycosphingolipid Antigens: Their Structure, Organization, and Function

  1998influential citation
• Differential Expression of α2,6-Sialyltransferase in Colon Tumors Recognized by a Monoclonal Antibody

  1998cites this paper
• Differential expression of the cancer associated antigens T (Thomsen-Friedenreich) and Tn to the skin in primary and metastatic carcinomas.

  1998cites this paper
• Colon carcinoma glycoproteins carrying α 2,6‐linked sialic acid reactive with Sambucus Nigra agglutinin are not constitutively expressed in normal human colon mucosa and are distinct from sialyl‐tn antigen

  1997cites this paper
• A possible role for enzymes in tumour-cell invasion

  1997cites this paper